Up next

Autoplay

Latest analysis of the ELIANA trial for acute lymphocytic leukemia

3 Views • 08/04/23
Share
Embed
administrator
administrator
Subscribers
0

Dr Stefan Grupp gives a press conference at ASH 2018 about the ELIANA trial.

He diescribes how tisagenlecleucel continues to show durable remissions in paediatric and young patients with relapsed or treatment-resistant acute lymphocytic leukaemia.

Watch his interview with ecancer here:

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay